{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:57:02Z","timestamp":1773421022474,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1053\/j.jrn.2010.10.014","type":"journal-article","created":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T09:26:54Z","timestamp":1293874014000},"page":"87-91","source":"Crossref","is-referenced-by-count":41,"title":["Adiponectin and Leptin in Chronic Kidney Disease: Causal Factors or Mere Risk Markers?"],"prefix":"10.1053","volume":"21","author":[{"given":"Carmine","family":"Zoccali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Mallamaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2010.10.014_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","article-title":"Body mass index and risk for end-stage renal disease","volume":"144","author":"Hsu","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jrn.2010.10.014_bib2","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.2337\/diabetes.54.11.3095","article-title":"The human glomerular podocyte is a novel target for insulin action","volume":"54","author":"Coward","year":"2005","journal-title":"Diabetes"},{"key":"10.1053\/j.jrn.2010.10.014_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/labinvest.3780392","article-title":"Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats","volume":"82","author":"Hoshi","year":"2002","journal-title":"Lab Invest"},{"key":"10.1053\/j.jrn.2010.10.014_bib4","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1053\/j.ajkd.2006.07.025","article-title":"Podocyte lesions in patients with obesity-related glomerulopathy","volume":"48","author":"Chen","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2010.10.014_bib5","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1161\/ATVBAHA.107.147645","article-title":"Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice","volume":"27","author":"Ohashi","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.jrn.2010.10.014_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1681\/ASN.V131134","article-title":"Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease","volume":"13","author":"Zoccali","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl","key":"10.1053\/j.jrn.2010.10.014_bib7","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1046\/j.1523-1755.63.s84.49.x","article-title":"Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors","author":"Zoccali","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.10.014_bib8","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/sj.ki.5002191","article-title":"Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study","volume":"71","author":"Kollerits","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.10.014_bib9","first-page":"1645","article-title":"Adiponectin regulates albuminuria and podocyte function in mice","volume":"118","author":"Sharma","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2010.10.014_bib10","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2010.10.014_bib11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1523-1755.1999.00626.x","article-title":"Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis","volume":"56","author":"Wolf","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.10.014_bib12","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1046\/j.1523-1755.1998.00088.x","article-title":"Low leptin gene expression and hyperleptinemia in chronic renal failure","volume":"54","author":"Nordfors","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.10.014_bib13","first-page":"343","article-title":"Renal disease in partial lipodystrophy","volume":"41","author":"Eisinger","year":"1972","journal-title":"Q J Med"},{"key":"10.1053\/j.jrn.2010.10.014_bib14","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.2337\/diabetes.54.7.2206","article-title":"Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients","volume":"54","author":"Pistrosch","year":"2005","journal-title":"Diabetes"},{"key":"10.1053\/j.jrn.2010.10.014_bib15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2337\/dc07-1868","article-title":"Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial","volume":"31","author":"Dagenais","year":"2008","journal-title":"Diabetes Care"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105122761000289X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105122761000289X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T19:39:21Z","timestamp":1637091561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105122761000289X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S105122761000289X"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2010.10.014","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}